# Ceftriaxone in the Management of Bipolar Depression

> **NCT00566111** · NA · TERMINATED · sponsor: **Yale University** · enrollment: 5 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** ceftriaxone
- **DRUG:** Saline solution

## Key facts

- **NCT ID:** NCT00566111
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Early indication of an unfavorable risk/benefit ratio.
- **Last updated:** 2020-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00566111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00566111, "Ceftriaxone in the Management of Bipolar Depression". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00566111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*